Treatment of Vaccinia and Cowpox Virus Infections in Mice with CMX001 and ST-246. - Wikidata - awgldk - TriplyDB

Treatment of Vaccinia and Cowpox Virus Infections in Mice with CMX001 and ST-246.

Treatment of Vaccinia and Cowpox Virus Infections in Mice with CMX001 and ST-246.

http://www.wikidata.org/entity/Q35260533

about

A cutting-edge view on the current state of antiviral drug development.A single cidofovir treatment rescues animals at progressive stages of lethal orthopoxvirus disease.Low-resolution structure of vaccinia virus DNA replication machinery Both CD8+ and CD4+ T Cells Contribute to Corneal Clouding and Viral Clearance following Vaccinia Virus Infection in C57BL/6 Mice Orthopoxvirus inhibitors that are active in animal models: an update from 2008 to 2012.ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrapping.Antiviral Activity of Lady's Mantle (Alchemilla vulgaris L.) Extracts against Orthopoxviruses.Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses.Challenges and Achievements in Prevention and Treatment of Smallpox.

P2860

Q34036018-5CA3CF9E-9F01-4236-92B3-B4A717F94856 Q36130201-D53A0B37-0A4F-41B1-BFE2-0089C9D57232 Q36559777-1F88EAA4-6B26-4732-866E-E16F5B8091FD Q37073359-A6EFB57A-8538-44D0-935A-A4F7ABCEA02C Q37593480-39F90E5E-54EA-458F-AC29-6F8DC996D9F4 Q39046951-E42BC7B7-DCC7-4F5E-A24D-33ABC20E8C04 Q40108301-ED1B0089-EBEA-4E3A-A952-4390EF2B0521 Q42200165-30614B03-69B7-4B55-8F7E-AFDEEF89AF1C Q47547852-C9F1F174-9478-4286-9261-8165BBFE03B1

P2860

Treatment of Vaccinia and Cowpox Virus Infections in Mice with CMX001 and ST-246.

http://www.wikidata.org/entity/Q35260533

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Treatment of Vaccinia and Cowpox Virus Infections in Mice with CMX001 and ST-246.

@ast

Treatment of Vaccinia and Cowpox Virus Infections in Mice with CMX001 and ST-246.

@en

type

label

Treatment of Vaccinia and Cowpox Virus Infections in Mice with CMX001 and ST-246.

@ast

Treatment of Vaccinia and Cowpox Virus Infections in Mice with CMX001 and ST-246.

@en

prefLabel

Treatment of Vaccinia and Cowpox Virus Infections in Mice with CMX001 and ST-246.

@ast

Treatment of Vaccinia and Cowpox Virus Infections in Mice with CMX001 and ST-246.

@en

P1433

Q35260533-314C41D1-5FA8-45BF-8662-D9BF5D833154

P1476

Q35260533-939B29EB-DF83-4E26-AC64-697BE21C4F88

P2093

Q35260533-94B16476-3381-4A38-8D6C-4ADB5DF0E200

Q35260533-EB81F8D5-132F-4D37-9A4E-E27EA6DD8047

P2860

Q35260533-08994E3D-27C4-4CA3-9137-DEE98E0A9A4C

Q35260533-1481FB06-8284-4EE0-BC9E-5E326B0D22DE

Q35260533-25804947-1F7D-4ECC-AD8B-915018E0FE23

Q35260533-276A3861-7DF6-4E4C-9844-7EAEB9AB5B94

Q35260533-2A7F5059-D188-4C19-9D21-223632D538FA

Q35260533-3566F38B-FD1A-49B3-B158-1DD81D4615D9

Q35260533-3F46FE7F-C3BE-4AF4-84E0-4B4411CC3128

Q35260533-4B2C007F-1F19-4D44-83E5-5F0FBF5E8FB2

Q35260533-4C19E168-2153-432E-80FB-177A9F69A649

Q35260533-5C155876-7050-4E24-B970-95809631976B

P304

Q35260533-227810B8-E4D2-41BA-A6B8-5373CBA4BA2C

P31

Q35260533-C03A99AC-41E5-41B2-93E3-1889DE038261

P356

Q35260533-F658EE3C-ACAE-4316-A262-C4EE2D4F4F9A

P433

Q35260533-A9DEF76F-AC2A-4D41-B551-3078687E7781

P478

Q35260533-08B30871-92EF-45BF-90AB-6141514A9AD5

P577

Q35260533-5443449A-1473-43B8-A848-CECA40ABD39A

P5875

Q35260533-3D24112D-6A43-4155-A284-FE791EEE0018

P698

Q35260533-7C1F80BD-F8C2-41C1-8C07-0C973BB16F8E

P932

Q35260533-B7E0C8B6-5291-445C-9302-38CE20239C64

P356

P1433

P1476

Treatment of Vaccinia and Cowpox Virus Infections in Mice with CMX001 and ST-246.

@en

P2093

Debra C Quenelle

http://www.w3.org/2001/XMLSchema#string

Earl R Kern

http://www.w3.org/2001/XMLSchema#string

P2860

An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge

Efficacy of CMX001 against herpes simplex virus infections in mice and correlations with drug distribution studies

The smallpox story: life and death of an old disease

Efficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in mice

Efficacy of ST-246 versus lethal poxvirus challenge in immunodeficient mice

Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir

Cidofovir in the treatment of poxvirus infections.

Rethinking smallpox.

A review of compounds exhibiting anti-orthopoxvirus activity in animal models.

Evaluation of nucleoside phosphonates and their analogs and prodrugs for inhibition of orthopoxvirus replication.

P304

2681-2695

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/V2122681

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51711968

http://www.w3.org/2001/XMLSchema#string

P698

21994637

http://www.w3.org/2001/XMLSchema#string

P932

3185598

http://www.w3.org/2001/XMLSchema#string